Active substance (DCI)
- furoate de fluticasone
- vilantérol
                    	
                    		
                    		
                    	
                    	
                    	
	                    
		                    
		                    
		                    	Technical information
		                    	
		                    
		                    
		                    
		                    	
			                    	Manufacturer
			                    	GLAXOSMITHKLINE
			                     
		                    	
		                   
			                   
			                    	Presentation
			                    	
 
 
  
   REVINTY ELLIPTA 92 microgrammes/22 microgrammes, poudre pour inhalation en récipient unidose (code CIS : 64050311)
     3 inhalateurs (3 x 30 doses) (CIP : 34009 302 085 1 9)
   REVINTY ELLIPTA 184 microgrammes/22 microgrammes, poudre pour inhalation en récipient unidose (code CIS : 68680154) Bande thermoformée aluminium de 30 dose(s) avec 1 inhalateur unidose (CIP : 34009 300 786 7 9)
     3 inhalateurs (3 x 30 doses) (CIP : 34009 302 085 2 6)
   
 
 
			                     
		                    
	                     
	                    
	                    
	                    
	
                	 
               	 
                
             
         
     
	
        
  
			
		
	
	
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
eNrFWF1v2jAUfedXRHlPQqAf6RSoNtZuSK3GKGjTXiqT3BQz105tJ8B+/RxCtXRy1NbU6iO2c+6177nHB8fnm3vilMAFZnTghn7XdYAmLMX0buDOZ5de5J4PO/EKlaix7NTv+mHPdRKChBi41ay/AESF//P66jOo74G7w44Ts8UKEvlkXSEx8b8isbxGebXGiUuGU+ce5JKlAzcv5G7UiYXkKovhmvHfIkcJxMF+pDm7uj1qjsdBBfYC1EIAv0L0TgsK1AgzKTgHKkdIwh3jWy10ltz2otOTbjcyCoHFFAQreAITJJcTzkqcQqqPhIgAoyDZOr0BXhKQVRAteLBK7oUROFqhzRQexvqkP6rZkdxIr+uFpyfhWS/qR0dRr2cUijeOSk8etYkgz3l62zuL+mHUD4AGHEpM5dYDQnAukZcVnKmKeil4GVHkTZBgFAKvxARRCZwRw0pOGJeIWKohFqOnbLQUh8PDs1xJscgJ2vorkZseFeJITQNXmmFvI9UOZlypGFFn9h8+LQgJXpn1fK8xljKuJGzECipbpOZyanoQI6aIvWmvqJk6ys2eixjE28H+Uc2oRZsUC4ITUwFUElWAkPPpuF3/3k86PiEBc25PO35gmrK1eHtNanLAUvb5Tla1oKpcYVWvk/D42LjlfqkSttxeF6reOQRKrbA4RITGNGOHyo/isB7qkcHvRN6d8WIJItBivTxD3VKsfXSK1vrCXs/VE1rQLxczUzJ9L4Bvb3Y/tdA4HTRpYKbrNi4Lxd7W3F/fC7UkvMCXH0V9M6tZcL3iLKXMxYcgWK/X/hIJT1St42f8ne+PxgVv7z+EFRdRu6pagy2lvqgv19fV07RDn/MZh3rn/fd7j66NIXkBB9SiFnNrkju+eHsV/2ecraU9eSI59sLsTC6SmFFbdqpY6L3UofeGKi295EojvmUZbnndaaVmHNQvS8NOHFSvSsPOXyDWMvk=
CceymeL2DjJUG4XB